Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Disruption of Robo2-Baiap2 integrated signaling drives cystic disease
Qinggang Li, … , Xiaogang Li, Xiangmei Chen
Qinggang Li, … , Xiaogang Li, Xiangmei Chen
Published September 19, 2019
Citation Information: JCI Insight. 2019;4(18):e127602. https://doi.org/10.1172/jci.insight.127602.
View: Text | PDF
Research Article Development Nephrology

Disruption of Robo2-Baiap2 integrated signaling drives cystic disease

  • Text
  • PDF
Abstract

Hereditary renal cystic diseases are characterized by defects in primary cilia of renal tubular epithelial cells and abnormality of tubular epithelium, which ultimately result in the development of renal cysts. However, the mechanism leading from abnormality of the tubular epithelium to cystogenesis is not well understood. In this report, we demonstrate a critical role for Robo2 in regulating epithelial development, including ciliogenesis, polarization, and differentiation. We found that Robo2 deficiency results in cystic kidneys, and the cyst cells showed defective cilia and polarity defects in tubular epithelium. The cyst cells, less than terminally differentiated, continue to proliferate. We further established that Robo2 works with p53 as well as polarity and ciliary proteins (Par3, PKCς, ZO-2, and Claudin-2) to regulate these processes. Robo2 binds to Baiap2 (also known as IRSp53) through the IRSp53/MIM homology domain in renal epithelial cells. This binding allows Robo2 to phosphorylate MDM2 at Ser166 via Baiap2 and maintain p53 homeostasis. Disruption of the Robo2-Baiap2 complex causes MDM2 to be subjected to dephosphorylation, leading to a high level of active p53, and initiated p53-mediated cellular senescence via p21 and decreased the expression of ZO-1, ZO-2, PKCς, Par3, and Claudin-2 proteins, resulting in defects in epithelial development, including ciliogenesis, polarization, and differentiation. Importantly, double knockout of Robo2 and p53 rescued all the epithelial defects in kidneys compared with those in Robo2-knockout kidneys. Taken together, the present results demonstrate that Robo2 deficiency causes renal cystic disease, which is largely dependent on defective Robo2-Baiap2 integrated signaling in kidneys.

Authors

Qinggang Li, Shaoyuan Cui, Qian Ma, Ying Liu, Hongyu Yu, GuangRui Geng, Ewud Agborbesong, Chongyu Ren, Kai Wei, Yingjie Zhang, Jurong Yang, Xueyuan Bai, Guangyan Cai, Yuansheng Xie, Xiaogang Li, Xiangmei Chen

×

Figure 4

Disruption of Robo2-Baiap2 signaling results in p53-mediated cellular senescence.

Options: View larger image (or click on image) Download as PowerPoint
Disruption of Robo2-Baiap2 signaling results in p53-mediated cellular se...
(A) IF staining of p53 in Robo2-knockdown MDCK cells. Scale bars: 20 μm. (B) IF staining of γ-H2AX in Robo2-knockdown MDCK cells. The red dots just show the labeling of siRNA with Cy3 (Robo2 siRNA). Scale bars: 20 μm. (C) Knockdown of Baiap2 or Robo2 increased the expression of γ-H2AX in MDCK cells. Data are mean ± SEM. *P < 0.05 compared with control group, 1-way ANOVA with Dunnett’s post hoc test. (D) Staining of SAβ-Gal in E17 wild-type and Robo2–/– kidneys. Scale bars: 50 μm. Original magnification, ×400 (inset). (E) Knockout of Robo2 decreased the phosphorylation of MDM2 at Ser166 in Robo2–/– kidneys. Scale bars: 10 μm. (F) Knockdown of Robo2 decreased the phosphorylation of MDM2 at Ser166 in MDCK cells. Data are mean ± SEM. **P < 0.01 by 2-tailed Student’s t test. (G) Knockdown of Baiap2 also decreased the phosphorylation of MDM2 at Ser166. Data are mean ± SEM. *P < 0.05; **P < 0.01 by 2-tailed Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts